Jun
2017
Vol. 36. No. 3
Jun
2013
Vol. 32. No. 2
Sep
2017
Vol. 36. No. 3
Curriculum United for Better Eczema Care: why, how, and what?
While various medical specialties treat eczema patients, care for these patients is largely fragmented and disorganized.
MORE
Dec
2017
Vol. 36. No. 4
Emerging Science and Management of Atopic Dermatitis, Introduction
The landscape of atopic dermatitis has evolved rapidly in recent years. The introduction of crisaborole, a phosphodiesterase-4 inhibitor, enables clinicians to offer another nonsteroidal topical therapy to patients with mild to moderate disease. The approval of dupilumab—an interleukin-4 and interleukin-13 inhibitor and the first biologic to become available for the treatment of atopic dermatitis—has revolutionized the therapy of adults with moderate to severe disease.
Mar
2017
Vol. 36. No. 2
Meeting the Challenge of Atopic Dermatitis from Infancy to Adulthood, Introduction
Dermatologists and primary care clinicians have been able to adequately manage most patients with atopic dermatitis (AD), using long-standing and familiar nonpharmacologic and pharmacologic interventions.